Drug Discovery Unit, Dundee
The DDU is housed in purpose built modern laboratories allowing all disciplines to be located in close proximity.
Please feel free to Contact Us
The DDU is housed in purpose built modern laboratories allowing all disciplines to be located in close proximity.
Please feel free to Contact Us
One of the major initiatives of the DDU is the discovery of leads and pre-clinical candidates for the treatment of diseases such as sleeping sickness and leishmaniasis.
See our Major Initiatives
We are investigating highly innovative targets and pathways to validate them and establish proof of principle.
See our Major Initiatives
We have a purpose-built screening laboratory with a suite of assay technologies and automated liquid handling to enable concurrent screening of a broad range of target and assay types.
See our Capabilities
We have a medicinal chemistry team with a large amount of experience from the Pharmaceutical/ Biotech sector.
See our Capabilities
Involved in library selection, assessment of hits and drug design.
See our Capabilities
The DMPK group has state of the art UPLC-MSMS technology for supporting hit to lead and lead optimisation programmes.
See our Capabilities
The aims of the DDU are to produce leads and candidates suitable for entry into formal preclinical development.
The Dundee Drug Discovery Unit has two major initiatives, neglected tropical diseases and innovative targets and pathways. Major Initiatives
The DDU is a fully operational and integrated drug discovery team with the full range of disciplines needed for drug discovery. Capabilities
We have a healthy pipeline of molecular targets in both the neglected tropical diseases initiative and the innovative targets and pathways initiative.
Current Portfolio
July 2008
The Dundee Drug Discovery Unit (DDU) was founded in 2006 in the College of Life Sciences, University of Dundee, with the aim of translating basic science into lead compounds to validate putative drug targets, to use as tools to investigate disease pathways and, when appropriate, advance to pre-clinical drug candidates. The DDU works to Biotech style philosophy and standards incorporating, dynamic, goal driven Project Management based on Target Product Profiles and Compound Selection Criteria. The DDU has two major research focuses.
The DDU has all of the capabilities required for early phase drug discovery: assay development, high throughput screening, cell biology, medicinal chemistry, structural biology, computational chemistry and DMPK. All of these capabilities operate under one management structure to ensure an integrated approach and rapid progress.
Currently the team is about 30 people and includes substantial experience from the pharmaceutical/ biotech sector. This website contains details of current programmes and supporting infrastructure.
Please feel free to Contact Us.